For too long, cancer treatment has been a double-edged sword – the very treatments designed to kill cancer cells often wrought havoc on healthy ones too.
An innovative use of IGA antibodies to target and kill tumor-promoting molecules found deep within cancer cells revealed notable reductions in tumor growth and minimal side effects in mice with lung and colon cancer.